Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2025 Jul;32(7):2270-2282.
doi: 10.1007/s43032-025-01908-5. Epub 2025 Jun 19.

Mass Spectrometry-Based Untargeted Metabolomics Identifies Distinct Metabolic Signatures in Infertility: A Comparative Analysis of PCOS, POR, and NOR

Metin Demirel  1 , Mehtap Alim  2   3 , Fatmanur Koktasoglu  2 , Nil Atakul  4 , Ebru Guner  4 , Ayse Nur Işık Aydın  4 , Sanem Naz Kafali  5 , Yildız Atamer  6 , Sahabettin Selek  2
Affiliations
Comparative Study

Mass Spectrometry-Based Untargeted Metabolomics Identifies Distinct Metabolic Signatures in Infertility: A Comparative Analysis of PCOS, POR, and NOR

Metin Demirel et al. Reprod Sci. 2025 Jul.

Abstract

Background: Infertility affects approximately 15% of reproductive-age couples, with polycystic ovary syndrome and poor ovarian reserve being major contributing factors. Metabolomic profiling of follicular fluid offers insights into the underlying metabolic disturbances associated with these infertility phenotypes. This study aims to identify metabolic biomarkers distinguishing PCOS, POR, and male factor infertility, which may facilitate improved diagnostic and therapeutic strategies.

Methods: A total of 119 participants were categorized into three groups: PCOS (n = 39), POR (n = 40), and NOR (n = 40). Liquid chromatography-high-resolution mass spectrometry was used for untargeted metabolomic profiling. Metabolites were identified using HMDB, MassBank, and MoNA, while pathway analysis was performed using KEGG. Statistical analyses were conducted using R and Python, including one-way ANOVA, t-tests, and Mann-Whitney U tests, with False Discovery Rate correction applied.

Results: Distinct metabolic alterations were observed among the groups. Trehalose-6-phosphate, taurocholate, and N,N-dimethylglycine emerged as the most significantly altered metabolites, showing strong discriminatory potential between PCOS and POR. PCOS patients exhibited reduced levels of taurocholate, mycalemide, and trehalose-6-phosphate, whereas NOR patients showed elevated levels of N,N-dimethylglycine and argininosuccinate. The POR group demonstrated increased levels of 1-methyl-2-pyrrolidone and haplopine, along with a broader metabolite distribution.

Conclusion: This study reveals phenotype-specific metabolic signatures in PCOS and POR, identifying taurocholate, mycalemide, and N,N-dimethylglycine as potential follicular biomarkers. These findings contribute to a deeper understanding of the metabolic basis of infertility and highlight the potential of follicular fluid metabolomics for precision medicine in reproductive health.

Keywords: Follicular fluid; Infertility; Metabolic pathways; Polycystic ovary syndrome; Poor ovarian reserve; Taurocholate; Trehalose-6-phosphate; Untargeted metabolomics.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflicts of Interest: The authors declare no conflicts of interest related to this study. Ethics Approval: This study was approved by the Research Ethics Committee of Bezmialem Vakıf University (Approval Number: 173773) Consent to Participate: All participants provided written informed consent prior to their inclusion in the study. Consent for Publication: All authors have reviewed and approved the manuscript for publication.

Figures

Fig. 1
Fig. 1
OPLS-DA and PCA analyses among NOR, POR, and PCOS groups
Fig. 2
Fig. 2
Distribution of metabolites among NOR, POR, and PCOS groups (ns: not significant; *: p < 0.05; **: p < 0.01.)
Fig. 3
Fig. 3
Correlation analysis of metabolites and hormones in the POR group
Fig. 4
Fig. 4
Correlation analysis of metabolites and hormones in the PCOS group
Fig. 5
Fig. 5
Pathway enrichment analysis of metabolic differences between PCOS and POR
Fig. 6
Fig. 6
ROC analysis between POR and PCOS groups
See this image and copyright information in PMC

References

    1. World Health Organization. Infertility prevalence estimates, 1990–2021. World Health Organization; 2023.
    1. Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev. 2015;36:487–525. 10.1210/er.2015-1018. - DOI - PMC - PubMed
    1. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–7. 10.1093/humrep/deh098. - DOI - PubMed
    1. Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L, et al. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26:1616–24. 10.1093/humrep/der092. - DOI - PubMed
    1. Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev. 2009;30:465–93. 10.1210/er.2009-0006. - DOI - PubMed

Publication types

LinkOut - more resources